Novel Bifunctional Bisphosphonates for the Detection and Therapy of Bone Metastases

被引：0

作者：

de Rosales, R. Torres Martin ^{[1
]}

Finucane, C. ^{[2
]}

Mather, S. J. ^{[2
]}

Blower, P. J. ^{[1
]}

机构：

[1] Kings Coll London, Div Imaging Sci, London WC2R 2LS, England

[2] Barts & London Queen Marys Sch Med & Dent, Inst Canc, Ctr Mol Oncol & Imaging, London, England

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：S353 / S353

页数：1

共 50 条

[21] Role of bisphosphonates in prostate cancer bone metastases
Guise, TA
Chirgwin, JM
SEMINARS IN ONCOLOGY, 2003, 30 (05) : 717 - 723
[22] Bone Metastases in Lung Cancer: The role of bisphosphonates
Marketos, Ch.
PNEUMON, 2006, 19 (04) : 324 - 338
[23] Bisphosphonates in Breast Cancer Patients with Bone Metastases
Diel, Ingo J.
BREAST CARE, 2010, 5 (05) : 306 - 311
[24] Bisphosphonates in the prevention of bone metastases: Current evidence
Diel, IJ
SEMINARS IN ONCOLOGY, 2001, 28 (04) : 75 - 80
[25] The emerging role of bisphosphonates in the prevention of bone metastases
Paterson, AHG
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01): : 24 - 29
[26] Therapy of bone metastases. Importance of osteoclast inhibition by bisphosphonates or RANK ligand inhibition
Link, H.
ONKOLOGE, 2014, 20 (08): : 766 - 771
[27] Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?
Daniel Keizman
Maya Ish-Shalom
Natalie Maimon
Maya Gottfried
World Journal of Urology, 2014, 32 : 39 - 45
[28] Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?
Keizman, Daniel
Ish-Shalom, Maya
Maimon, Natalie
Gottfried, Maya
WORLD JOURNAL OF UROLOGY, 2014, 32 (01) : 39 - 45
[29] Bisphosphonates spearhead new approach to treating bone metastases
Bankhead, C
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 115 - 116
[30] Bisphosphonates in the treatment of bone metastases in prostate cancer (PCA).
Voreuther, R
Heidenreich, A
Engelmann, UH
JOURNAL OF UROLOGY, 1998, 159 (05): : 335 - 335

← 1 2 3 4 5 →